photo of Michelle Jang, MD

Michelle Jang, MD

Internal Medicine
location icon
HSS - Main Hospital535 East 70th Street
New York, NY 10021
Tel: 212.606.1679
Fax: 212.774.2010

About Dr. Jang

Departments

Internal Medicine

Insurance

Aetna
BCBS Federal
BCBS Anthem of NY (formerly Empire)
BCBS Horizon
Cigna
Connecticare (not through Access Health CT)
EmblemHealth GHI
EmblemHealth HIP
EmblemHealth Medicare
EmblemHealth Select Care
The Empire Plan / NYSHIP
Medicare Part B
Oxford
UnitedHealthcare
UnitedHealthcare Compass
UnitedHealthcare Medicare HMO
UnitedHealthcare Medicare PPO

If your insurance is not listed, please call our office if you have questions regarding your insurance coverage. If you have out-of-network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.

Credentials

Appointments

Attending Physician, Hospital for Special Surgery

Certification

Internal Medicine Board Certification

Education

Robert Wood Johnson Medical School, 2013

Internship

Icahn School of Medicine at Mount Sinai, 2014

Residency

Icahn School of Medicine at Mount Sinai, 2016

State Licensure

New York

Languages

English, Korean

Industry Relationships

Industry Relationships

HSS has a long history of supporting appropriate relationships with industry because they advance HSS's mission to provide the highest quality patient care, improve patient mobility, and enhance the quality of life for all, and to advance the science of orthopedic surgery, rheumatology, and their related disciplines through research and education.

As of May 11, 2024, Dr. Dr. Jang reported no relationships with the healthcare industry.

HSS and its physicians make this information available to patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest and Commitment Policy prohibits physicians from collecting royalties on products they develop that are used on patients at HSS.